These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Pulmonary hypertension and HIV: implementation of a Regional Registry]. Petrosillo N; Chinello P; Vizza D; Cicalini S Infez Med; 2005 Mar; 13(1):5-15. PubMed ID: 15888976 [TBL] [Abstract][Full Text] [Related]
10. Combination drug therapy in the management of pulmonary arterial hypertension. Kayser SR Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142 [No Abstract] [Full Text] [Related]
11. Treatments for pulmonary arterial hypertension. Liu C; Liu K; Ji Z; Liu G Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344 [TBL] [Abstract][Full Text] [Related]
12. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-hemodynamic study and treatment of 44 patients with primary pulmonary hypertension]. Roman A; Rodés-Cabau J; Lara B; Bravo C; Monforte V; Pallissa E; Domingo E; Morell F Med Clin (Barc); 2002 Jun; 118(20):761-6. PubMed ID: 12049690 [TBL] [Abstract][Full Text] [Related]
14. [Current views on the use of vasodilators in pulmonary hypertension]. Ceriana P; De Amici D; Pagnin A; Braschi A Minerva Cardioangiol; 1995 Jun; 43(6):273-9. PubMed ID: 7566540 [TBL] [Abstract][Full Text] [Related]
15. Vasodilators in the treatment of primary pulmonary hypertension. Weir EK; Schremmer B Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771 [No Abstract] [Full Text] [Related]
16. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan. Beghetti M Eur J Clin Invest; 2006 Sep; 36 Suppl 3():16-24. PubMed ID: 16919006 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery. Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102 [TBL] [Abstract][Full Text] [Related]
18. Inhaled Therapies for Pulmonary Hypertension. Hill NS; Preston IR; Roberts KE Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575 [TBL] [Abstract][Full Text] [Related]
19. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203 [TBL] [Abstract][Full Text] [Related]
20. Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension. Gildea TR; Arroliga AC; Minai OA Cleve Clin J Med; 2003 Apr; 70 Suppl 1():S18-27. PubMed ID: 12716139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]